The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype Jia-Chun MaXiao-Rong ZhongHong Zheng Breast Oncology 12 February 2021 Pages: 5084 - 5095
ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype Jia-Chun MaXiao-Rong ZhongLei Liu ASO Author Reflections 18 February 2021 Pages: 5096 - 5097
Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR) Minhao LvJuntao LiSuxia Luo Breast Oncology 17 February 2021 Pages: 5098 - 5109
ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer Minhao LvSuxia Luo ASO Author Reflections Open access 02 February 2021 Pages: 5110 - 5111
Characteristics and Long-Term Risk of Breast Angiosarcoma Ann-Kristin U. FriedrichEmily S. ReisenbichlerDonald R. Lannin Breast Oncology 18 February 2021 Pages: 5112 - 5118
ASO Author Reflections: Breast Angiosarcoma—A Rare Disease with a Lot of Uncertainty Ann-Kristin U. FriedrichDonald R. Lannin ASO Author Reflections 23 February 2021 Pages: 5119 - 5120
Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator Michael M. JonczykCarla Suzanne FisherAbhishek Chatterjee Breast Oncology 22 February 2021 Pages: 5121 - 5131
ASO Author Reflections: Predicting Complications in Breast Cancer Surgery Using the BCSRc Michael M. JonczykAbhishek Chatterjee ASO Author Reflections 26 February 2021 Pages: 5132 - 5133
Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination Patrick J. McCormickMelissa AsselRebecca S. Twersky Breast Oncology 24 February 2021 Pages: 5134 - 5140
ASO Author Reflections: We No Longer Give Ketorolac During Mastectomy. Should You? Patrick J. McCormickBrett A. Simon ASO Author Reflections 05 March 2021 Pages: 5141 - 5141
Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery Cindy CenJennifer ChunFreya Schnabel Breast Oncology 26 February 2021 Pages: 5142 - 5148
Radial Scars and Complex Sclerosing Lesions of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance Elizabeth KraftJessica N. LimbergJennifer L. Marti Breast Oncology 05 March 2021 Pages: 5149 - 5155
ASO Author Reflections: “High-Risk” Lesions of the Breast: Low Risk of Cancer, High Risk of Overtreatment Jennifer L. Marti ASO Author Reflections 29 March 2021 Pages: 5156 - 5157
Patients Older 65 Years With Early Breast Cancer Prefer Intraoperative Radiation as a Locoregional Treatment Choice Annie TangCaitlin M. CohanVeronica C. Shim Breast Oncology 09 March 2021 Pages: 5158 - 5163
ASO Author Reflections: Balancing Patient Choice and Risks/Benefits of Radiation Treatment in Early Breast Cancer: How Does One Choose? Annie TangVeronica Shim ASO Author Reflections 06 March 2021 Pages: 5164 - 5165
Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: The LYMPH-Q Upper Extremity Module Anne F. KlassenElena TsangarisAndrea L. Pusic Reconstructive Oncology Open access 05 July 2021 Pages: 5166 - 5182
Development and Psychometric Validation of the BREAST-Q Animation Deformity Scale for Women Undergoing an Implant-Based Breast Reconstruction After Mastectomy Elena TsangarisAndrea L. PusicAnne F. Klassen Reconstructive Oncology 26 February 2021 Pages: 5183 - 5193
Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible Esmée A. DijkstraVéronique E. M. MulBoudewijn van Etten Colorectal Cancer Open access 22 May 2021 Pages: 5194 - 5204
Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal Adenocarcinoma Seth I. FelderSujata PatilJulio Garcia-Aguilar Colorectal Cancer 01 April 2021 Pages: 5205 - 5223
ASO Author Reflections: Endoscopic Rectal Cancer Response to Neoadjuvant Therapy: Qualitative or Quantitative Interpretation? Seth I. FelderJulio Garcia-Aguilar ASO Author Reflections 01 April 2021 Pages: 5224 - 5225
Elderly Patients Have Better Quality of Life but Worse Survival Following Pelvic Exenteration: A 25-Year Single-Center Experience Raha AlahmadiDaniel SteffensCherry E. Koh Colorectal Cancer 09 March 2021 Pages: 5226 - 5235
ASO Author Reflections: Quality of Life and Survival Outcomes in Elderly Patients Undergoing Pelvic Exenteration Raha AlahmadiMichael J. SolomonDaniel Steffens ASO Author Reflections 02 March 2021 Pages: 5236 - 5237
Neoadjuvant Short-Course Radiotherapy for Upper Third Rectal Tumors: Systematic Review and Individual Patient Data Metaanalysis of Randomized Controlled Trials Michael FlanaganCillian ClancyJohn Burke Colorectal Cancer 12 March 2021 Pages: 5238 - 5249
ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone Michael FlanaganCillian ClancyJohn Burke ASO Author Reflections 29 March 2021 Pages: 5250 - 5251
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Ebbe Billmann ThorgersenJørund AsvallKjersti Flatmark Peritoneal Surface Malignancy Open access 21 May 2021 Pages: 5252 - 5262
ASO Author Reflections: The Peritoneum is an Active Immunological Compartment Ebbe Billmann ThorgersenKjersti Flatmark ASO Author Reflections Open access 03 May 2021 Pages: 5263 - 5264
Impact of Enhanced Recovery After Surgery on Postoperative Outcomes for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Bradley WhiteFadi DahdalehGeorge I. Salti Peritoneal Surface Malignancy 19 January 2021 Pages: 5265 - 5272
ASO Author Reflections: Enhanced Recovery After CRS/HIPEC—An Opportunity to Meet Quality Standards Fadi S. DahdalehBradley WhiteGeorge I. Salti ASO Author Reflections 08 January 2021 Pages: 5273 - 5274
Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases Nicolas TabchouriJonathan BuggischUrs Giger-Pabst Peritoneal Surface Malignancy 20 January 2021 Pages: 5275 - 5286
Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score Caroline J. RieserLauren B. HallM. Haroon A. Choudry Peritoneal Surface Malignancy Open access 23 January 2021 Pages: 5287 - 5296
The Impact of Thoracic Epidural Analgesia Versus Four Quadrant Transversus Abdominis Plane Block on Quality of Recovery After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Surgery: A Single-Center, Noninferiority, Randomized, Controlled Trial Juan P. CataKeith FournierOn behalf of the HIPEC study group Peritoneal Surface Malignancy 03 February 2021 Pages: 5297 - 5310
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC) Koen P. RoversEmma C. E. WassenaarIgnace H. J. T. de Hingh Peritoneal Surface Malignancy 05 February 2021 Pages: 5311 - 5326
ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases Koen P. RoversRobin J. LurvinkIgnace H. J. T. de Hingh ASO Author Reflections 19 January 2021 Pages: 5327 - 5329
Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious Shachar LaksGal SchtrechmanAviram Nissan Peritoneal Surface Malignancy 16 February 2021 Pages: 5330 - 5338
ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases S. LaksM. AdilehA. Nissan ASO Author Reflections 18 February 2021 Pages: 5339 - 5340
Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy Yoshinori MatsudaShintaro NaritaTomonori Habuchi Urologic Oncology 09 June 2021 Pages: 5341 - 5348
Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer Ryohei KufukiharaEiji KikuchiMototsugu Oya Urologic Oncology 05 March 2021 Pages: 5349 - 5359
ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer Ryohei KufukiharaEiji KikuchiMototsugu Oya ASO Author Reflections 27 March 2021 Pages: 5360 - 5361
Clinical Importance of CD200 Expression in Colorectal Liver Metastasis Yasuko MatsuoMasayuki ShoYosuke Iwasa Translational Research 03 January 2021 Pages: 5362 - 5372
Expression Status of Serine Protease 27: A Prognostic Marker for Esophageal Squamous Cell Carcinoma Treated with Preoperative Chemotherapy/Chemoradiotherapy Atsuko KataokaKazuhiko YamadaYuki I. Kawamura Translational Research 15 January 2021 Pages: 5373 - 5381
ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment Atsuko KataokaKazuhiko YamadaYuki I. Kawamura ASO Author Reflections 16 January 2021 Pages: 5382 - 5383
Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma Masato MitsudaAtsushi ShiozakiEigo Otsuji Translational Research 09 February 2021 Pages: 5384 - 5397
ASO Author Reflections: Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma Masato MitsudaAtsushi ShiozakiEigo Otsuji ASO Author Reflections 15 February 2021 Pages: 5398 - 5399
Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells Atsushi ShiozakiKeita KatsuraharaEigo Otsuji Translational Research 10 February 2021 Pages: 5400 - 5411
ASO Author Reflections: Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors Suppressed the Growth of Gastric Cancer Stem Cells Atsushi ShiozakiKeita KatsuraharaEigo Otsuji ASO Author Reflections 08 February 2021 Pages: 5412 - 5413
End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma Daniel R. RiceJ. Madison HyerTimothy M. Pawlik Hepatobiliary Tumors 02 February 2021 Pages: 5414 - 5422
ASO Author Reflections: Optimizing End-of-Life Care for Patients Dying from Hepatocellular Carcinoma Daniel R. RiceTimothy M. Pawlik ASO Author Reflections 31 January 2021 Pages: 5423 - 5424
ASO Visual Abstract: End-of-Life Hospice Utilization and Medicare Expenditures Among Patients Dying from Hepatocellular Carcinoma Daniel R. RiceJ. Madison HyerTimothy M. Pawlik ASO Visual Abstract 16 April 2021 Pages: 5425 - 5425
Venous Reconstruction During Pancreatectomy Using Polytetrafluoroethylene Grafts: A Single-Center Experience with Standardized Perioperative Management Jonathan GarnierEddy TraversariOlivier Turrini Pancreatic Tumors 02 March 2021 Pages: 5426 - 5433
ASO Author Reflections: Venous Axis Reconstruction During Pancreatectomies: Polytetrafluoroethylene Grafting Should Not Be the Last Option Jonathan GarnierJacques EwaldOlivier Turrini ASO Author Reflections 04 March 2021 Pages: 5434 - 5435